• Exchange: Stuttgart
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

FAD1:GR

8.632 EUR 1.719 24.87%

As of 13:58:33 ET on 01/27/2015.

Snapshot for Advaxis Inc (FAD1)

Open: 7.173 Day's Range: 6.990 - 8.632 Volume: 600
Previous Close: 6.913 52wk Range: 1.746 - 11.801 1-Yr Rtn: +145.09%

Stock Chart for FAD1

No chart data available.
  • FAD1:GR 8.602
  • 1D
  • 1M
  • 1Y
6.913
Interactive FAD1 Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for FAD1

Current P/E Ratio (ttm) -
Estimated P/E(10/2015) -
Relative P/E vs. DAX -
Earnings Per Share (USD) (ttm) -
Est. EPS (USD) (10/2015) -1.1100
Est. PEG Ratio -
Market Cap (M EUR) 204.10
Shares Outstanding (M) 23.64
30 Day Average Volume 1,380
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 03/17/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for FAD1

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for FAD1

Advaxis Inc., is a biotechnology company. The Company develops therapeutic cancer vaccines targeting cervical, head & neck, breast, prostate, and other cancers.

Daniel J O'ConnorPresident/CEOGregory T Mayes "Greg"Exec VP/COO
Robert PetitExec VP/Chief Scientific OfcrSara BonsteinSenior VP/CFO
More Company Profile & Key Executives for FAD1

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil